Biovail Founder Strikes Deal In SEC Fraud Suit

Law360, New York (February 18, 2011, 2:05 PM EST) -- Biovail Corp.'s founder and former CEO has settled a fraud suit accusing the Canada-based pharmaceutical company and its former principals of overstating earnings and hiding losses from 2001 to 2003.

Eugene N. Melnyk agreed to a $150,000 civil penalty without admitting or denying the allegations filed against him by the U.S. Securities and Exchange Commission, according to Thursday's final judgment in the U.S. District Court for the Southern District of New York.

The payment will be funneled into a fund that may be distributed at a...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Securities and Exchange Commission v. Biovail Corporation et al


Case Number

1:08-cv-02979

Court

New York Southern

Nature of Suit

Securities/Commodities

Judge

Lewis A. Kaplan

Date Filed

March 20, 2008

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.